Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ
VanEck Pharmaceutical ETF (PPH -0.68%) provides concentrated exposure to global drugmakers, while iShares Global Healthcare ETF (IXJ -0.48%) offers broader access to the wider healthcare sector, including equipment and services companies. Investors…
How Pharma Stocks Reacted To Trump's 200% Tariff Threat On Generic Drugs
The shares of Indian pharmaceutical companies plummeted in early trade on Wednesday, July 22, after the US President Donald Trump, announced a phased tariff imposition plan linked to generic drugs. The Nifty Pharma fell nearly 2% in trade on…
Swiss pharma firm Sandoz takes note of proposed US tariffs on generic drugs
“At this stage, it is too early to assess the potential implications, as further details on the implementation and scope of this measure are still required”, particularly regarding the group's geographical presence and its…
Trump's tariff threat on generic drugs: Why this matters for Indian pharma companies
4 min read New Delhi Make us preferred source on Google US President Donald Trump on Tuesday (July 21) said that tariffs on generic drugs in the US will be raised 100% after two years and to 200% thereafter to “reshore” generic pharma…
Trump's 200% generic tariff threat would imperil Americans: Indian pharma
U.S. President Donald Trump has given generic pharmaceutical companies a two-year window to establish manufacturing facilities in the United States, warning that products imported after August 2028 could face tariffs of up to 200%. The…
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma 'On Notice'; Goldman Flags Reshoring Winners
President Trump will impose a 100% tariff on imported generic drugs starting in August 2028, rising to 200% a year later, unless manufacturers shift production to the US. 'This is done in order to RESHORE Generic Pharmaceutical Production into…
Pharma stocks decline; Aurobindo Pharma down over 4%
Pharma stocks declined on Wednesday, with Aurobindo Pharma tumbling over 4 per cent, after US President Donald Trump announced steep tariffs on imported generic medicines from August 2028, asserting that the move was aimed at onshoring the…
Indian pharma sees little immediate threat in Trump's 200% tariff plan
While the Indian generic pharmaceutical industry so far remained unscathed during several rounds of US tariff announcements, US President Donal Trump on Wednesday in a Truth Social post said tariffs on economical generics from India will be raised…
Markets in pressure at midday; banking, IT, pharma drag; auto bucks trend
Markets remained under significant pressure through Wednesday's midday session, with the Sensex and Nifty sliding sharply as selling intensified across banking, information technology, and pharmaceutical stocks. As of 12.50 pm, the Sensex was…
Stock Market Today: Why Are Sensex And Nifty Falling? Pharma Tariffs, Rising Oil Weigh | Dynamite News
Post Published By: Ayushi Bisht Updated: 22 July 2026, 10:20 AM IST Mumbai: Indian benchmark indices extended their losses during early trade on Wednesday, with selling pressure spreading across pharmaceutical, banking, information technology and…
Trump's proposed 200% tariff is a wake-up call, India's bigger pharma risk lies in China, say experts
India reportedly supplies 47% of all generic prescriptions dispensed in the United States, making India the country's largest source of affordable generic medicines. With US President Donald Trump proposing tariffs of up to 200% on generic drug…
US tariff threat drags Nifty Pharma 1.4% lower; Lupin, Auropharma lead decline
Pharma stocks fell sharply on Wednesday after the US proposed steep tariffs on generic drug imports, with the Nifty Pharma Index dropping 374 points, or 1.43 per cent, to 25,718 by afternoon trade. Only two of the index's 20 constituents ended in…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Still a Buy?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up prior to trading on Wednesday. The stock had previously closed at $18.37, but opened at $19.31. Ascentage Pharma Group International shares last traded…
Indian drugmakers rattled by Trump's 100% levy on generics
U.S. President Donald Trump's plan to impose steep tariffs on generic medicines has unsettled Indian drugmakers and put the spotlight on their strategy in their biggest export market. The NSE Nifty Pharma Index slipped 1.3% in Mumbai Wednesday…
Peptides May Soon Be Legal. These Companies Are Ready To Cash In
W hen the FDA panel that's considering whether to recommend legal production of seven peptides meets starting Thursday, Shaun Noorian will be at its Maryland campus in person. “I wouldn't miss it for the world,” Noorian, the founder…
Receive a Daily briefing on Pharma Industry News
Get Started